comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 21:48:35 - browse：534

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Pharma’s losing bet in New Jersey

WSS

6 solutions to address cancer drug shortages and others

New research sheds light on how often breast cancer is overdiagnosed

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Should insurance cover cosmetic surgery?

Decentralized clinical trials need collaboration to achieve wider use

IVG is promising — but it won’t replace IVF quite yet

knowledge

comprehensive

focus

Heart attack and stroke risk calculators need revising

Unmasking the 'centricity' illusion in clinical trials

Anesthesiologist group: stop taking Ozempic before surgery

Louisiana bill approved classifying abortion pills as controlled substances

Heart attack and stroke risk calculators need revising

Why we need mandatory labeling of GMO products

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Louisiana bill approved classifying abortion pills as controlled substances

In age of alternative facts, a scholarly course on calling out crap

Ozempic cut risk of death in diabetes patients with chronic kidney disease

leisure time

Should insurance cover cosmetic surgery?

Experts study whether long Covid risk adds up with each reinfection

2023 Nobel Prize in Medicine goes to Karikó and Weissman

The world needs the new pandemic treaty

Lawsuit highlights wrinkle for disputes over surprise medical bills

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

entertainment

hotspot

entertainment

explore